2025-05-13T09:17:15-05:00 2024-06-30 861065772 DELOITTE TAX LLP 695 TOWN CENTER DRIVE SUITE 1000 COSTA MESA CA 92606 990 2023-07-01 620646012 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC STJU 8882785833 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 PAT KEEL EVP, CFO 8882785833 2025-05-12 1 0 JOHN W SADOFF JR P00540589 7144367100 2023 2025-03-06 01:10:19Z JAMES R DOWNING 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 2011010826 0 X WWW.STJUDE.ORG X 1959 TN THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER DANNY THOMAS, NO CHILD IS DENIED TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S ABILITY TO PAY. 36 34 7374 396 0 0 1514862066 1840997693 153766510 126053527 919411 3349819 37696084 39452878 1707244071 2009853917 12884704 5299920 0 0 769429557 935470881 0 0 0 736734912 831907622 1519049173 1772678423 188194898 237175494 10479499175 11651284051 277577319 328077153 10201921856 11323206898 X THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER DANNY THOMAS, NO CHILD IS DENIED (CONTINUED ON SCHEDULE O) TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S ABILITY TO PAY. 0 0 823242799 267998 1568264 RESEARCH: THE CURRENT BASIC SCIENCE AND CLINICAL RESEARCH AT THE HOSPITAL INCLUDES WORK IN GENE THERAPY, CHEMOTHERAPY, THE BIOCHEMISTRY OF NORMAL AND CANCEROUS CELLS, RADIATION TREATMENT, BLOOD DISEASES, RESISTANCE TO THERAPY, VIRUSES, NEUROLOGICAL DISEASES, HEREDITARY DISEASES, INFLUENZA, PEDIATRIC AIDS AND PHYSIOLOGICAL EFFECTS OF CATASTROPHIC ILLNESSES. 695612476 12500 131592234 PATIENT CARE: THE HOSPITAL PROVIDED 17,449 INPATIENT DAYS OF CARE DURING THE YEAR. OUR BONE MARROW TRANSPLANTATION PROGRAM ACCOUNTED FOR 3,187 OR 18% OF THOSE INPATIENT DAYS. PATIENTS MADE 72,606 CLINIC REGISTRATIONS DURING THE YEAR. 113586397 5019422 EDUCATION AND TRAINING: AS PART OF ITS MISSION, THE HOSPITAL HAS DEVELOPED A GLOBAL INITIATIVE (ST. JUDE GLOBAL) TO IMPROVE THE SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE. ST. JUDE GLOBAL ACCOMPLISHES THIS BY SHARING KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS, HELPING TO IMPLEMENT NEW APPROACHES TO TREAT PEDIATRIC CANCER GLOBALLY, AND DEVELOPING REGIONAL NETWORKS COMMITTED TO ERADICATING CANCER IN CHILDREN. THIS MISSION WILL BE ACHIEVED BY FOCUSING ON THREE OVERRIDING GOALS: (1) TO TRAIN THE CLINICAL WORKFORCE THAT WILL BE REQUIRED TO MEET OUR MISSION, (2) TO DEVELOP AND STRENGTHEN HEALTH SYSTEMS AND PATIENT-CENTERED INITIATIVES THAT ENCOMPASS THE ENTIRE CONTINUUM OF CARE REQUIRED FOR CHILDREN WITH CANCER AND NON-MALIGNANT HEMATOLOGICAL (CONTINUED ON SCHEDULE O) DISEASES, AND (3) TO ADVANCE KNOWLEDGE IN GLOBAL PEDIATRIC ONCOLOGY AND HEMATOLOGY THROUGH RESEARCH TO SUSTAIN A CONTINUOUS IMPROVEMENT IN THE LEVEL AND QUALITY OF CARE DELIVERED AROUND THE GLOBE. THESE INITIATIVES ARE SPEARHEADED BY ST. JUDE EXPERTS WHO WORK CLOSELY WITH HEALTHCARE PROFESSIONALS AT OUR PARTNER SITES. IN ADDITION GRADUATE PROGRAMS AT BOTH THE MASTER'S AND DOCTORAL LEVELS ARE OFFERED THROUGH A WHOLLY OWNED SUBSIDIARY, ST. JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, LLC, TO EDUCATE AND TRAIN FUTURE GENERATIONS OF BIOMEDICAL RESEARCHERS AND MEDICAL PROFESSIONALS SEEKING TO PROBE THE MOLECULAR BASIS OF DISEASE, DEVELOP NOVEL THERAPIES AND ADVANCE GLOBAL HEALTH FOR CHILDREN WITH PEDIATRIC CATASTROPHIC DISEASES. 1632441672 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 1 1 1 1 0 0 0 1 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 1 1510 0 1 7374 1 0 0 0 0 0 0 0 0 0 0 1 0 X 36 34 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 TN X X JULIE MEYER 8882785833 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 JAMES R DOWNING PRESIDENT/CEO 55.00 1.00 X X 2368582 0 65608 RICHARD C SHADYAC JR EX-OFFICIO DIRECTOR 1.00 55.00 X 0 1295514 166273 JOYCE A ABOUSSIE VOTING DIRECTOR 4.00 4.00 X 0 0 0 STEVEN J ALLEN MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH S AYOUB JR ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL J AYOUB ESQ VOTING DIRECTOR 8.00 4.00 X 0 0 0 FREDERICK M AZAR MD VOTING DIRECTOR 4.00 8.00 X 0 0 0 MARTHA PERINE BEARD VOTING DIRECTOR 4.00 8.00 X 0 0 0 ROBERT A BREIT MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 TERRY L BURMAN VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH M DEVIVO VOTING DIRECTOR (THRU 11/23) 4.00 4.00 X 0 0 0 LISA R DILLER MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH E EID MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 FRED P GATTAS III PHARMD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JUDY A HABIB VOTING DIRECTOR 8.00 4.00 X 0 0 0 GABRIEL G HADDAD MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHARLES C HAJJAR VOTING DIRECTOR 4.00 4.00 X 0 0 0 FOUAD A HAJJAR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 FREDERICK R HARRIS JR MD VOTING DIRECTOR 8.00 4.00 X 0 0 0 J DAVID KARAM II VOTING DIRECTOR 4.00 8.00 X 0 0 0 SCOTT A KUPOR VOTING DIRECTOR 4.00 4.00 X 0 0 0 SHARON L MCCOLLAM VOTING DIRECTOR 4.00 4.00 X 0 0 0 SAMIA MELHEM VOTING DIRECTOR 4.00 4.00 X 0 0 0 ROBERT T MOLINET ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 NEELA M MONTGOMERY VOTING DIRECTOR 4.00 4.00 X 0 0 0 RAMZI N NUWAYHID VOTING DIRECTOR 4.00 4.00 X 0 0 0 THOMAS J PENN III VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHRISTINA M RASHID VOTING DIRECTOR 4.00 4.00 X 0 0 0 KATHRYNE G REEVES VOTING DIRECTOR 4.00 4.00 X 0 0 0 CAMILLE F SARROUF JR ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH C SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH G SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 GEORGE A SIMON II VOTING DIRECTOR 4.00 4.00 X 0 0 0 MICHAEL C SIMON VOTING DIRECTOR 4.00 4.00 X 0 0 0 TONY THOMAS VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL H WEIN ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 TAMA H ZAYDON VOTING DIRECTOR 4.00 4.00 X 0 0 0 ELLIS NEUFELD EVP/CLINICAL DIRECTOR 55.00 0.00 X 1251455 0 68108 CHARLES M ROBERTS EVP/DIRECTOR CANCER CENTER 55.00 0.00 X 1078877 0 126952 JOSEPH P TAYLOR EVP/SCIENTIFIC DIRECTOR 55.00 0.00 X 974146 0 219307 PATRICIA A KEEL EVP, CAO & CFO 55.00 0.00 X 1086065 0 60275 CARLOS RODRIGUEZ-GALINDO EVP/CHAIR 55.00 0.00 X 896171 0 105110 MICHAEL DYER CHAIR 55.00 0.00 X 1163148 0 74225 THOMAS E MERCHANT CHAIR 55.00 0.00 X 1068890 0 76725 ANDREW DAVIDOFF CHAIR 55.00 0.00 X 1010679 0 72011 DAVID ELLISON CHAIR 55.00 0.00 X 897273 0 50526 AMAR GAJJAR CHAIR 55.00 0.00 X 868746 0 56898 JAMES I MORGAN FORMER OFFICER 55.00 0.00 X 531527 0 67640 13195559 1295514 1209658 2098 1 1 0 FLINTCO LLC 2179 HILLSHIRE CIRCLE MEMPHIS TN 38133 CONSTRUCTION COMPANY 126497574 IMPACT ADVISORS LLC PO BOX 379 NAPERVILLE IL 605660379 CONSULTING SERVICES 18529403 ACCENTURE LLP 500 W MADISON ST CHICAGO IL 606612592 CONSULTING SERVICES 18124550 BELZ CONSTRUCTION SERVICES LLC 100 PEABODY PLACE STE 1400 MEMPHIS TN 38103 CONSTRUCTION COMPANY 7760202 DELL MARKETING LP PO BOX 534118 ATLANTA GA 303534118 SOFTWARE SUPPORT 5708960 112 1677081481 142430747 21485465 1840997693 PATIENT CARE 621110 126053527 126053527 126053527 2640711 2640711 27897560 27897560 1498422 367595 924097 232812 574325 134783 709108 231853 477255 CAFETERIA/VENDING 722514 4486967 4486967 CHGME/CHCA 900099 3792561 3792561 OTHER CONTRACT REVENUE 900099 1175000 1175000 2100790 1907557 193233 11555318 2009853917 133160498 0 35695726 X 280498 280498 5019422 5019422 8052975 4637382 3415593 623577 623577 698476450 641864466 56611984 42975088 40290926 2684162 136045089 126882709 9162380 49297702 45962249 3335453 55299372 49563104 5736268 2684595 2406726 277869 244262 218835 25427 104894 104894 193397089 155154244 38242845 2205394 1977125 228269 6236750 5843476 393274 123306795 110543941 12762854 56652467 45041927 11610540 27121786 25680907 1440879 3997103 2736102 1261001 55189 42431 12758 120365142 108884216 11480926 3301307 2257184 1044123 LABORATORY SUPPLIES 88588940 87181104 1407836 PHARMACEUTICAL SUPPLIES 78326558 77081809 1244749 TELEPHONE 2303334 2231847 71487 ALLOCATION ADJUSTMENTS 0 33115082 -33115082 67716645 56920383 10796262 1772678423 1632441672 140236751 0 7022061 3420283 7374875 41473083 50967811 26214195 32331999 16554556 17213755 32072612 35628569 2832353193 1341682411 1236092088 1490670782 3315585 3666296 25000 25000 9116729995 10009984681 10479499175 11651284051 183592110 209211393 8991108 7658758 84994101 111207002 277577319 328077153 X 8909051856 9944661557 1292870000 1378545341 10201921856 11323206898 10479499175 11651284051 X 237175494 7382719 876726829 X 0 1 X 1 1 1 X 1094131374 1130870648 1236970064 1514862066 1840997693 6817831845 1094131374 1130870648 1236970064 1514862066 1840997693 6817831845 6817831845 9206868 7628043 22090006 29913745 30538271 99376933 9142582 6485751 8793618 9981926 11555318 45959195 6963167973 126053527 0.97910 0.97900 X PART II, SECTION B, LINE 10: EXPLANATION FOR OTHER INCOME: 2019 $ 3,706,979 - CAFETERIA/VENDING $ 2,511,652 - CHGME/CHCA $ 314,924 - HHMI $ 2,609,027 - OTHER REVENUE $ 9,142,582 - TOTAL OTHER INCOME 2020 $ 1,852,003 - CAFETERIA/VENDING $ 2,513,042 - CHGME/CHCA $ 196,501 - HHMI $ 1,924,205 - OTHER REVENUE $ 6,485,751 - TOTAL OTHER INCOME 2021 $ 3,073,670 - CAFETERIA/VENDING $ 2,811,538 - CHGME/CHCA $ 173,725 - HHMI $ 2,734,685 - OTHER REVENUE $ 8,793,618 - TOTAL OTHER INCOME 2022 $ 4,539,294 - CHGME/CHCA $ 3,862,130 - CAFETERIA/VENDING $ 164,989 - GIFT SHOP $ 1,415,513 - OTHER REVENUE $ 9,981,926 - TOTAL OTHER INCOME 2023 $ 4,486,967 - CAFETERIA/VENDING $ 3,792,561 - CHGME/CHCA $ 1,175,000 - OTHER CONTRACT REVENUE $ 2,100,790 - OTHER REVENUE $ 11,555,318 - TOTAL OTHER INCOME RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 1 50584 1 46182 0 1 8128 104894 0 PART II-B, LINE 1: LINE 1A) VOLUNTEERS CONSISTED OF A ST. JUDE SURVIVOR AND FAMILY MEMBER WHO PARTICIPATED IN THE CHA FAMILY ADVOCACY DAY; LINE 1B) ST. JUDE EMPLOYS AN OFFICE OF GOVERNMENT AFFAIRS; LINE 1F) AMOUNT LISTED IS CONTRIBUTION TO THE CHGME ADVOCACY CAMPAIGN; LINE 1G) AMOUNT LISTED IS PRORATED SALARY OF CHIEF GOVERNMENT AFFAIRS OFFICER AND STAFF PLUS TRAVEL EXPENSES; LINE 1I) AMOUNT LISTED IS RELATED TO PRORATED RETAINER FEES FOR DIRECT FEDERAL AND STATE LEGISLATIVE CONTACTS AS WELL AS PROFESSIONAL DUES ATTRIBUTABLE TO LOBBYING FOR THE CHGME ADVOCACY PROGRAM. 1265819894 11394005 130976228 44658585 1363531542 1209550774 2023095 70264947 16018922 1265819894 1329927343 9150000 -59754448 69772121 1209550774 1033682990 7863768 357550674 69170089 1329927343 1055350944 5491426 34726892 61886272 1033682990 0.08700 0.91300 0 1 1 1928827464 746934938 1181892526 4221973 1359018 2862955 872956123 578398683 294557440 26347633 14989772 11357861 1490670782 INTEREST IN NET ASSETS OF AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC 9843840829 OTHER ASSETS 140382966 RIGHT OF USE OPERATING ASSETS 25760886 10009984681 NOTE PAYABLE 2054180 SELF INSURANCE LIABILITY 3479738 WORKERS COMPENSATION 1220490 OWNER CONTROLLED INSURANCE PROGRAM 388948 LONG TERM LEASE LIABILITY 18134261 TECH LICENSING DISTRIBUTIONS PAYABLE - NON CURRENT 3639431 DEFERRED COMPENSATION 82289954 111207002 X 1131206641 7382717 791051488 798434205 332772436 1677081481 1677081481 2009853917 1772678423 0 1772678423 0 1772678423 PART V, LINE 4: THE ENDOWMENT FUNDS ARE HELD BY AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC., A RELATED ORGANIZATION, AND ARE USED TO SUPPORT THE FUTURE NEEDS OF ST. JUDE. PART X, LINE 2: AS OF JUNE 30, 2024, THE ORGANIZATION HAD NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS UNDER ASC TOPIC 740, INCOME TAXES, REQUIRING ADJUSTMENTS TO ITS COMBINED FINANCIAL STATEMENTS. IN THE EVENT THE ORGANIZATION WERE TO RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IT WOULD BE RECOGNIZED IN THE COMBINED FINANCIAL STATEMENTS AS A GENERAL EXPENSE. GENERALLY, TAX YEARS ENDING 2020 THROUGH 2022 ARE OPEN TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES, RESPECTIVELY. THERE ARE NO INCOME TAX EXAMINATIONS CURRENTLY IN PROCESS. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN INTEREST IN NET ASSETS OF ALSAC WITHOUT DONOR RESTRICTIONS 791,051,488. PART XI, LINE 4B - OTHER ADJUSTMENTS: NET SUPPORT RECEIVED FROM ALSAC 1,677,081,481. 1 CENTRAL AMERICA AND THE CARIBBEAN 0 3 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 1470087 EAST ASIA AND THE PACIFIC 0 1 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 4595851 EUROPE (INCLUDING ICELAND & GREENLAND) 0 5 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 5059727 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 4935086 NORTH AMERICA 0 1 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 1778995 RUSSIA AND NEIGHBORING STATES 0 2 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 371311 SOUTH AMERICA 0 4 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 2312800 SOUTH ASIA 0 4 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 807821 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES RESEARCH / EDUCATION AND TRAINING 593366 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTMAKING 48611 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 56439 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 500000 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 3150385 NORTH AMERICA 0 0 GRANTMAKING 264800 RUSSIA AND NEIGHBORING STATES 0 0 GRANTMAKING 665464 SOUTH AMERICA 0 0 GRANTMAKING 160142 SOUTH ASIA 0 0 GRANTMAKING 51870 SUB-SAHARAN AFRICA 0 0 GRANTMAKING 121711 0 20 0 0 0 20 21331678 5612788 26944466 EUROPE (INCLUDING ICELAND & GREENLAND) FINANCIAL SUPPORT 500000 ELECTRONIC FUND/WIRE TRANSFER 0 MIDDLE EAST AND NORTH AFRICA FINANCIAL SUPPORT 3102699 ELECTRONIC FUND/WIRE TRANSFER 0 RUSSIA AND NEIGHBORING STATES FINANCIAL SUPPORT 665464 ELECTRONIC FUND/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC SPONSORSHIP 20000 ELECTRONIC FUND/WIRE TRANSFER 0 NORTH AMERICA SPONSORSHIP 212420 ELECTRONIC FUND/WIRE TRANSFER 0 SOUTH AMERICA SPONSORSHIP 57000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA SPONSORSHIP 15000 ELECTRONIC FUND/WIRE TRANSFER 0 3 6 RESEARCH GRANT CENTRAL AMERICA AND THE CARIBBEAN 1 48611 ELECTRONIC FUND/WIRE TRANSFER RESEARCH GRANT EAST ASIA AND THE PACIFIC 1 36439 ELECTRONIC FUND/WIRE TRANSFER RESEARCH GRANT MIDDLE EAST AND NORTH AFRICA 1 47686 ELECTRONIC FUND/WIRE TRANSFER RESEARCH GRANT NORTH AMERICA 1 52380 ELECTRONIC FUND/WIRE TRANSFER RESEARCH GRANT SOUTH AMERICA 2 103142 ELECTRONIC FUND/WIRE TRANSFER RESEARCH GRANT SOUTH ASIA 1 51870 ELECTRONIC FUND/WIRE TRANSFER RESEARCH GRANT SUB-SAHARAN AFRICA 2 106711 ELECTRONIC FUND/WIRE TRANSFER 0 0 0 0 0 0 PART I, LINE 2: ST. JUDE CHILDREN'S RESEARCH HOSPITAL PERFORMS DUE DILIGENCE IN THE SELECTION PROCESS FOR ORGANIZATIONS THAT RECEIVE FINANCIAL SUPPORT AND SPONSORSHIPS, AND THE INTENDED PURPOSE OF THESE FUNDS ARE OUTLINED TO ENSURE THE SUPPORT IS USED APPROPRIATELY. ST. JUDE CHILDREN'S RESEARCH HOSPITAL PROVIDES GRANT FUNDING FOR INDIVIDUALS THAT HAVE COMPLETED THE MASTER OF SCIENCE IN GLOBAL CHILD HEALTH PROGRAM AT THE ST. JUDE GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS GRANT FUNDING REQUIRES AN APPROVED PROJECT PLAN, BUDGET, AND SUPPORTING APPLICATION. GRANT AGREEMENTS REQUIRE PROGRESS AND FINANCIAL REPORTING THROUGHOUT THE DEFINED TERM OF THE PROJECT. PART I, LINE 3: EXPENDITURES ARE RECORDED ON AN ACCRUAL BASIS. PAYMENTS ARE ISSUED BASED ON CONTRACTUAL OBLIGATIONS UPON RECEIPT OF SUPPORTING DOCUMENTATION. 1 1 0 0 1 1 1 0 0 144401964 2307323 142094641 0.08020 215871558 45668647 170202911 0.09600 12882174 2385756 10496418 0.00590 373155696 50361726 322793970 0.18210 113578600 263700 113314900 0.06390 26730091 1341273 25388818 0.01430 40164911 0 40164911 0.02270 749149750 185125100 564024650 0.31820 4853081 0 4853081 0.00270 934476433 186730073 747746360 0.42180 1307632129 237091799 1070540330 0.60390 78912 78912 0.00000 35769 35769 0.00000 114681 114681 0.00000 1 0 0 0 578873 -578873 X 1 1 1 1 ST JUDE CHILDREN'S RESEARCH HOSPITAL 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 WWW.STJUDE.ORG TN STATE LICENSE NUMBER 0000000113 X X X X ST JUDE CHILDREN'S RESEARCH HOSPITAL 1 0 0 1 X X X X X X X X X 21 1 0 0 1 X SEE PART V, SECTION C X 1 21 1 SEE PART V, SECTION C 0 1 X 1 1 X 1 X SEE PART V, SECTION C X SEE PART V, SECTION C X SEE PART V, SECTION C X X X X X X 1 X 0 X 1 X 0 0 ST. JUDE CHILDREN'S RESEARCH HOSPITAL PART V, SECTION B, LINE 5: THE FISCAL YEAR 2022 CHNA BUILDS UPON THE FISCAL YEAR 2019 CHNA AND REFLECTS THE ACTIVITIES IDENTIFIED IN THE FISCAL YEAR 2019 COMMUNITY BENEFIT IMPLEMENTATION PLAN FOR ST. JUDE. THE FISCAL YEAR 2022 CHNA WAS LED BY AN INTERNAL TEAM OF ST. JUDE STAFF MEMBERS. THE LEADERSHIP OF THIS TEAM ENGAGED HEALTH RESOURCES IN ACTION (HRIA), A NON-PROFIT PUBLIC HEALTH CONSULTANCY ORGANIZATION, TO CONDUCT THE CHNA. TO DEVELOP A SOCIAL, ECONOMIC, AND HEALTH PORTRAIT OF THE COMMUNITY SERVED BY ST. JUDE, HRIA REVIEWED EXISTING DATA DRAWN FROM ST. JUDE, LOCAL, STATE, AND NATIONAL SOURCES. IN ADDITION TO ANALYZING QUANTITATIVE DATA, HRIA CONDUCTED QUALITATIVE RESEARCH WITH INTERNAL AND EXTERNAL ST. JUDE STAKEHOLDERS AS WELL AS FAMILY MEMBERS AND FORMER PATIENTS IN ORDER TO SUPPLEMENT QUANTITATIVE FINDINGS WITH PERCEPTIONS OF COMMUNITY STRENGTHS AND ASSETS, PRIORITY HEALTH CONCERNS, AND SUGGESTIONS FOR FUTURE PROGRAMMING AND SERVICES. FOCUS GROUPS WERE CONDUCTED WITH CURRENT AND FORMER ST. JUDE PATIENTS, PATIENT CAREGIVERS, AND ST. JUDE CLINICAL, RESEARCH, AND ADMINISTRATIVE STAFF. DIFFERENT TOPIC AREAS WERE EXPLORED BASED ON THE UNIQUE EXPERIENCES OF EACH OF THE GROUPS. HRIA CONDUCTED 27 INTERVIEWS WITH 34 INDIVIDUALS; 13 INTERVIEWS WERE CONDUCTED WITH 19 STAFF OF ST. JUDE HOSPITAL, AND 12 INTERVIEWS WERE CONDUCTED WITH INDIVIDUALS FROM OUTSIDE THE ORGANIZATION. INTERVIEW PARTICIPANTS REPRESENTED A RANGE OF SECTORS, INCLUDING LEADERS IN HEALTH CARE AND HEALTH RESEARCH, GOVERNMENT, AND SOCIAL SERVICE ORGANIZATIONS FOCUSING ON VULNERABLE POPULATIONS. ADDITIONALLY, TWO INTERVIEWS WERE CONDUCTED WITH TWO FORMER ST. JUDE PATIENTS. EXTERNAL KEY INFORMANT INTERVIEWS WERE CONDUCTED WITH PEDIATRICS EAST, THE UNIVERSITY OF MEMPHIS, SCHOOL OF PUBLIC HEALTH, CHRIST COMMUNITY HEALTH SERVICES, LE BONHEUR CHILDREN'S HOSPITAL, TENNESSEE DEPARTMENT OF HEALTH, SHELBY COUNTY HEALTH DEPARTMENT, CHURCH HEALTH, AND SHELBY COUNTY GOVERNMENT. ST. JUDE CHILDREN'S RESEARCH HOSPITAL PART V, SECTION B, LINE 13H: NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. ALL PATIENTS ARE ELIGIBLE TO RECEIVE MEDICAL CARE AND SUPPORT SERVICES AT NO COST. THERE ARE NO TESTS OR THRESHOLDS APPLIED TO DETERMINE ELIGIBILITY FOR FINANCIAL ASSISTANCE. ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE REGARDLESS OF THEIR ABILITY TO PAY. ST. JUDE CHILDREN'S RESEARCH HOSPITAL PART V, SECTION B, LINE 15E: NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. ALL PATIENTS ARE ELIGIBLE TO RECEIVE MEDICAL CARE AND SUPPORT SERVICES AT NO COST. THERE ARE NO TESTS OR THRESHOLDS APPLIED TO DETERMINE ELIGIBILITY FOR FINANCIAL ASSISTANCE. ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE REGARDLESS OF THEIR ABILITY TO PAY. ST. JUDE CHILDREN'S RESEARCH HOSPITAL PART V, SECTION B, LINE 20E: ST. JUDE DOES NOT TAKE ANY OF THE COLLECTION ACTIONS DESCRIBED IN PART V, SECTION B, LINE 19 BECAUSE ST. JUDE COVERS ALL TREATMENTS, COPAYS, DEDUCTIBLES, COINSURANCE AND ANY OTHER COST SHARING OBLIGATIONS THAT ARE NOT COVERED BY INSURANCE. ST. JUDE TAKES NO ACTION TO COLLECT FROM PATIENTS OR THEIR FAMILIES AND DOES NOT REPORT TO CREDIT AGENCIES. ST. JUDE CHILDREN'S RESEARCH HOSPITAL: PART V, SECTION B, LINE 11: ST. JUDE CHILDREN'S RESEARCH HOSPITAL CONDUCTED AND ADOPTED ITS MOST RECENT COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) DURING TAX YEAR 2021 (FYE 6/30/22). ST. JUDE WILL FOCUS EFFORTS ON THE FOLLOWING COMMUNITY HEALTH NEEDS, LISTED IN ORDER OF PRIORITY, WHICH WILL BE ADDRESSED DURING TAX YEARS 2022-2024:AIM 1: IMPROVING ACCESS TO MENTAL HEALTH SUPPORTS AND SERVICES IN THE COMMUNITY, BEYOND THOSE RELATED TO PATIENT DIAGNOSIS AND TREATMENT. AIM 2: IMPROVING ACCESS TO PROVIDERS, RESOURCES, AND COORDINATED CARE DURING THE TRANSITION OF CARE FROM ST. JUDE AND ITS AFFILIATES TO COMMUNITY AND/OR ADULT CARE.AIM 3: IMPROVING ACCESS TO CLINICAL TRIALS AT ST. JUDE AND ITS AFFILIATES.AIM 4: CONDUCTING CANCER PREVENTION WORK THROUGH EDUCATION AND HPV VACCINATION.AIM 5: INCREASING AWARENESS AND EDUCATION OF SICKLE CELL DISEASE AND INFECTIOUS DISEASES (HIV/AIDS) IN THE COMMUNITY.AIM 6: STRENGTHEN COMMUNITY PARTNERSHIPS IN THE GREATER MEMPHIS AREA TO ADDRESS SOCIAL DETERMINANTS OF HEALTH FOR LOCAL PATIENTS.ALL SIGNIFICANT HEALTH NEEDS IDENTIFIED IN THE ST. JUDE CHILDREN'S RESEARCH HOSPITAL MOST RECENTLY CONDUCTED CHNA ARE BEING ADDRESSED. ST. JUDE CHILDREN'S RESEARCH HOSPITAL TOOK THE FOLLOWING ACTIONS DURING TAX YEAR 2023 WITH RESPECT TO ITS MOST RECENTLY CONDUCTED CHNA:AIM 1: IMPROVING ACCESS TO MENTAL HEALTH SUPPORTS AND SERVICES IN THE COMMUNITY, BEYOND THOSE RELATED TO PATIENT DIAGNOSIS AND TREATMENT.STRATEGY 1. EXPAND TELEMENTAL HEALTH OPTIONS FOR ST. JUDE PATIENTS AND CAREGIVERS WHEN THE NEED IS NOT RELATED TO DIAGNOSIS AND TREATMENT.ACTIONS TAKEN:- INITIATED THE PROCESS TO ACCEPT MEDICAID, WHICH WILL BE IMPORTANT FOR CONTINUITY OF CARE OF NEW REFERRALS AFTER COVERAGE BY ST. JUDE EXPIRES.- LAUNCHED REFERRALS FOR PATIENTS AND CAREGIVERS IN HEMATOLOGY CLINIC IN FEBRUARY 2024.STRATEGY 2. ENHANCE AND EXPAND AVAILABLE COMMUNITY MENTAL HEALTH RESOURCES FOR PATIENTS AND CAREGIVERS BY LEVERAGING PARTNERSHIPS AND COLLABORATIVE EFFORTS.ACTIONS TAKEN: - ST. JUDE OFFICE OF GOVERNMENT AFFAIRS CONTINUES TO ENGAGE AND ADVOCATE WITH STATE-LEVEL PUBLIC POLICY MAKERS FOR INTERSTATE COMPACTS THAT EXPAND MENTAL HEALTH PRACTICE (E.G.,PSYPACT AND SOCIAL WORK INTERSTATE COMPACTS.AIM 2: IMPROVING ACCESS TO PROVIDERS, RESOURCES, AND COORDINATED CARE DURING THE TRANSITION OF CARE FROM ST. JUDE AND ITS AFFILIATES TO COMMUNITY AND/OR ADULT CARE.STRATEGY 1. CONTINUE TO IMPROVE TRANSITION OPPORTUNITIES FOR ST. JUDE PATIENTS AFTER COMPLETION OF THERAPY. ACTIONS TAKEN: - SUCCESSFULLY IMPLEMENTED THE PATIENT TRANSITION GUIDE AND THE PATIENT TRANSITION TAB IN THE HEALTH RECORD WITHIN THREE PRIMARY ONCOLOGY CLINICS AS PART OF THE SUMMER 2024 PILOT. - DEVELOPED AN INTRANET SITE WITH TRAINING MATERIALS AND ALL PATIENT EDUCATION MATERIALS TOGETHER THAT INCREASED ACCESSIBILITY FOR CLINICIANS. - THE INSTITUTIONAL ROLLOUT OF STANDARDIZED TRANSITION PROCESSES BEGAN.AIM 3: IMPROVING ACCESS TO CLINICAL TRIALS AT ST. JUDE AND ITS AFFILIATES. STRATEGY 1. LAUNCH THE U-DECIDE TRIAL AT THE AFFILIATE CLINICS (THE DECISION TO ENROLL IN THERAPEUTIC CLINICAL TRIALS IN A PEDIATRIC CANCER CLINICAL NETWORK).ACTIONS TAKEN:- ENROLLED APPROXIMATELY 175 PATIENTS IN THE U-DECIDE TRIAL.- TWO AIMS OF THE STUDY ARE ENROLLING PATIENTS, THIRD AIM IS OPEN FOR ENROLLMENT.- VERBAL ADMINISTRATION OF SURVEY 1 REGARDING DEMOGRAPHICS TO 103 TRIAL PARTICIPANTS. - VERBAL ADMINISTRATION OF SURVEY 2 REGARDING DECISION MAKING PREFERENCES TO 18 TRIAL PARTICIPANTS. STRATEGY 2. CONTINUE TO IMPLEMENT OPERATIONAL STRATEGIES TO INCREASE LOCAL ACCESS TO AND ENROLLMENT IN CLINICAL TRIALS AT THE AFFILIATE LOCATIONS. ACTIONS TAKEN: - AFFILIATE PROVIDERS UTILIZING TOGETHER WEBSITE AS WELL AS THE ST. JUDE CARE AND TREATMENT SITE FOR CLINICAL TRIALS AVAILABLE.- ANNUAL AFFILIATE PHYSICIAN CONFERENCE HELD ON MARCH 22, 2024 FOCUSED ON PATIENT ENROLLMENTS.- ENHANCED CLINICAL OUTREACH AND EDUCATION COORDINATING COMMITTEE (COE) TO AUGMENT EDUCATIONAL ACTIVITIES FOCUSED ON CLINICAL RESEARCH AWARENESS AND PARTICIPATION.- CREATED NEW VOTING MEMBER OF CLINICAL TRIAL SCIENTIFIC REVIEW COMMITTEE.- IMPROVED UNDERREPRESENTED POPULATIONS IN CLINICAL RESEARCH.- ESTABLISHED SUBCOMMITTEE OF THE CANCER CENTER ADVISORY COMMITTEE.AIM 4: CONDUCTING CANCER PREVENTION WORK THROUGH EDUCATION AND HPV VACCINATION. STRATEGY 1. STRENGTHEN PARTNERSHIPS WITH LOCAL EDUCATION AGENCIES TO DISSEMINATE EDUCATIONAL PROGRAMS ON CANCER CONTROL AND PREVENTION. ACTIONS TAKEN: - EXPANDED THE AFTER-SCHOOL STEM CLUBS TO TWO ADDITIONAL SCHOOLS. - PILOTED THE VIRTUAL STEMM ACADEMY IN ONE HIGH SCHOOL.STRATEGY 2. SERVE AS A LEADER, CONVENER, AND CATALYST FOR IMPLEMENTING EVIDENCE-BASED INTERVENTIONS TO INCREASE HPV VACCINATION COVERAGE AND PREVENT HPV-ASSOCIATED CANCERS.ACTIONS TAKEN: - DEVELOPED AND IMPLEMENTED A LOCAL HPV VACCINATION ACTION PLAN FOR MEMPHIS, SHELBY COUNTY WITH APPROXIMATELY 150 LOCAL MEMBERS. - HOSTED 86 LEADERS ACROSS THE SOUTHEAST TO PRIORITIZE THREE EVIDENCE BASED INTERVENTIONS.STRATEGY 3. ENGAGE IN STRATEGIC IMPLEMENTATION OF EVIDENCE-BASED INTERVENTIONS TO INCREASE HPV VACCINATION COVERAGE.ACTIONS TAKEN: - DEVELOPED AND DISSEMINATED COMMUNICATIONS AT THE NATIONAL AND LOCAL LEVEL FOCUSED ON HPV CANCERS. - EXECUTED BACK TO SCHOOL VACCINATION EVENTS WITH MEMPHIS SHELBY COUNTY SCHOOLS, SHELBY COUNTY HEALTH DEPARTMENT, LE BONHEUR CHILDREN'S HOSPITAL, AND THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER. - ORGANIZED AND HOSTED A VARIETY OF SEMINARS AND CONFERENCES TO EDUCATE AND RAISE AWARENESS OF HPV AND CANCER VACCINES.AIM 5: INCREASING AWARENESS AND EDUCATION OF SICKLE CELL DISEASE AND INFECTIOUS DISEASES (HIV/AIDS) IN THE COMMUNITY.STRATEGY 1. DEVELOP ONLINE EDUCATIONAL MODULES ON SICKLE CELL TESTING AND GENETIC COUNSELING FOR TN DEPARTMENT OF HEALTH NURSES TO ENABLE THEM TO COMPLETE THE TRAINING AT THEIR CONVENIENCE. ACTIONS TAKEN: - LAUNCHED ONLINE EDUCATIONAL MODULE, 31 WEST TENNESSEE RURAL HEALTH DEPARTMENT NURSES COMPLETED TRAINING WITH INCREASES IN ASSESSMENT SCORES. - DISSEMINATED OF TRAIT MODULES AT ST. JUDE NURSING AND PSYCHOLOGY SYMPOSIUM, BLACK NURSES ASSOCIATION CONFERENCE IN ATLANTA, GA, AND AT THE ANNUAL SICKLE CELL AND THALASSEMIA CONFERENCE IN LONDON.STRATEGY 2. CREATE AND EXECUTE A COMMUNICATION CAMPAIGN THAT ADDRESSES THE GAPS IN KNOWLEDGE AND AWARENESS OF HIV AND THE HIV PREVENTION AND CARE PROGRAM AT ST. JUDE THAT PROVIDES RELATED PREVENTION AND TREATMENT.ACTIONS TAKEN: - IMPROVED MANAGEMENT OF SOCIAL MEDIA AND ACHIEVED INCREASES IN FOLLOWERS ACROSS SOCIAL MEDIA CHANNELS. - PRESENTED 4 TIMES ON HIV TO VARIOUS GROUPS IN SHELBY COUNTY WITH EFFORTS COVERED BY THE DAILY MEMPHIAN.- HOSTED TABLES AT 52 EVENTS AND MET WITH 15 COMMUNITY PARTNERS TO SHARE INFORMATION ABOUT HIV PREVENTION AND TREATMENT PROGRAMS AT ST. JUDE.STRATEGY 3. WITH A COALITION OF COMMUNITY STAKEHOLDERS, IDENTIFY THE GAPS IN THE CONTINUUM OF HIV PREVENTION AND CARE AND ADDRESS THOSE GAPS WITH A FOCUS ON STRUCTURAL CHANGE.ACTIONS TAKEN: - IMPLEMENTED A FRESH START WITH THE 18 MEMBER END HIV 901 COMMUNITY ADVISORY BOARD (CAB) TO RE-ENGAGE SUBCOMMITTEES.- CAB MEMBERS ATTENDED TECHNICAL ASSISTANCE TRAINING AS PART OF MEMBERSHIP RESPONSIBILITIES.- REINSTATED IN-PERSON CONNECT TO PROTEST (C2P) MEETING TO INCREASE PRODUCTIVITY AND INPUT FROM THE COMMUNITY. AIM 6: STRENGTHEN COMMUNITY PARTNERSHIPS IN THE GREATER MEMPHIS AREA TO ADDRESS SOCIAL DETERMINANTS OF HEALTH FOR LOCAL PATIENTS.STRATEGY 1. COLLABORATE WITH OTHER HEALTHCARE ORGANIZATIONS; LOCAL, STATE, AND NATIONAL GOVERNMENT AGENCIES; AND LOCAL COMMUNITY ORGANIZATIONS TO IMPROVE IDENTIFICATION AND UTILIZATION OF RESOURCES.ACTIONS TAKEN: - CONTINUED CONTRACT WITH THE WORKS, INC. (TWI), A COMMUNITY ORGANIZATION THAT ASSISTS WITH SECURING AFFORDABLE HOUSING AND SOCIAL SERVICES. - CONTINUED PARTNERSHIP WITH METROPOLITAN INTER-FAITH ASSOCIATION (MIFA) TO ASSIST FAMILIES WITHIN AND BEYOND SHELBY COUNTY WITH EMERGENCY RENT/MORTGAGE AND UTILITY PAYMENTS AND OTHER ASSISTANCE. - CONTINUED PRO BONO REFERRAL RELATIONSHIP WITH NATIONAL LAW FIRM FOR FAMILIES TO RECEIVE REPRESENTATION IN ISSUES LIKE CONSERVATORSHIPS, INDIVIDUAL EDUCATION PLANS, DISABILITY BENEFITS, FORECLOSURE, ETC.- IMPLEMENTED FORMAL ASSESSMENT OF DOMAINS OF FOOD SECURITY, FINANCIAL SECURITY AND INCOME STABILITY IN THE PSYCHOSOCIAL ASSESSMENT AND REASSESSMENT OF EVERY PATIENT.- WORKED WITH THE CONGRESSIONAL COLORECTAL CANCER CAUCUS TO SPONSOR LEGISLATION THAT WOULD INCORPORATE CHILDREN'S ONCOLOGY GROUP RECOMMENDATIONS FOR EARLY DIAGNOSTIC SCREENING FOR CERTAIN SURVIVORS OF CHILDHOOD CANCER INTO US PREVENTIVE SERVICES TASK FORCE GUIDELINES. ST. JUDE CHILDREN'S RESEARCH HOSPITAL: PART V, SECTION B, LINE 7A: THE CHNA REPORT WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/FINANCIALS/COMMUNITY-HEALTH-NEEDS-ASSESSMENT.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 10A: THE HOSPTIAL FACILITY'S MOST RECENTLY ADOPTED IMPLEMENTATION STRATEGY IS AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/ABOUT-ST-JUDE/FINANCIALS/COMMUNITY-HEALTH-NEEDS-ASSESSMENT.HTMLST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 14: ST. JUDE CURRENTLY DOES NOT BILL NOR PURSUE PAYMENT FOR ANY ST. JUDE PATIENT; THEREFORE, ST. JUDE DOES NOT HAVE A BASIS FOR CALCULATING AMOUNTS CHARGED TO PATIENTS.ST. JUDE CHILDREN'S RESEARCH HOSPITAL: PART V, SECTION B, LINE 16A: THE FAP WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML ST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 16B: BASED ON THE FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML), ST. JUDE DOES NOT HAVE AN APPLICATION FORM.ST. JUDE CHILDREN'S RESEARCH HOSPITAL:PART V, SECTION B, LINE 16C: A PLAIN LANGUAGE SUMMARY WAS MADE WIDELY AVAILABLE AT THE FOLLOWING URL: HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML 1 1 - SJCRH HOME CARE LLC 595 DANNY THOMAS PLACE SUITE K-1250 MEMPHIS TN 38105 HOME HEALTHY AGENCY PART I, LINE 3C: NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. ALL PATIENTS ARE ELIGIBLE TO RECEIVE MEDICAL CARE AND SUPPORT SERVICES AT NO COST. THERE ARE NO TESTS OR THRESHOLDS APPLIED TO DETERMINE ELIGIBILITY FOR FINANCIAL ASSISTANCE. ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE REGARDLESS OF THEIR ABILITY TO PAY. IF THE PATIENT HAS INSURANCE, ST. JUDE BILLS THE INSURANCE PLAN OR OTHER ORGANIZATION THAT PAYS HEALTH COSTS. PART I, LINE 7: COST-TO-CHARGE RATIO DERIVED FROM WORKSHEET 2, RATIO OF PATIENT CARE COST TO CHARGES. COST-TO-CHARGE RATIO USED FOR LINE 7A FINANCIAL ASSISTANCE AT COST, LINE 7B MEDICAID, AND LINE 7C COSTS OF OTHER MEANS-TESTED GOVERNMENT PROGRAMS. PART I, LINE 7G: ST. JUDE CHILDREN'S RESEARCH HOSPITAL INCLUDED AS SUBSIDIZED HEALTH SERVICES SUPPORT FOR EIGHT AFFILIATE CLINICS TOTALING APPROXIMATELY $10 MILLION. PART II, COMMUNITY BUILDING ACTIVITIES: ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS AN ACTIVE AND ENGAGED MEMBER OF THE MEMPHIS HEALTH COMMUNITY. EMPLOYEES PARTICIPATE IN BUSINESS, EDUCATION, OUTREACH AND CIVIC PROGRAMS AND ACTIVITIES FOSTERING COMMUNITY HEALTH IMPROVEMENT ADVOCACY, WHICH PROMOTE THE HEALTH AND WELLNESS OF THE COMMUNITIES WE SERVE. ACTIVITIES PROMOTE COLLABORATION ACROSS THE MEDICAL AND SCIENTIFIC COMMUNITIES TO BETTER SERVE INDIVIDUALS AND FAMILIES; ENHANCE COMMUNICATION TO SHARE KNOWLEDGE, EXPERIENCE AND INSIGHTS WHICH ARE ESSENTIAL FOR HEALTH ADVOCACY; AND EMPOWER EDUCATION AND AWARENESS TO FOSTER IMPROVED HEALTH BEHAVIORS INFLUENCING COMMUNITY HEALTH OUTCOMES.THE ST. JUDE CHILDREN'S RESEARCH HOSPITAL PRESIDENT AND CEO IS A MEMBER OF MEMPHIS TOMORROW, AN ASSOCIATION OF CHIEF EXECUTIVE OFFICERS OF MEMPHIS' LARGEST ENTERPRISES. THE PURPOSE IS TO BRING TOP BUSINESS LEADERS TOGETHER WITH GOVERNMENT AND CIVIC LEADERS TO FOSTER ECONOMIC PROSPERITY FOR ALL WHO LIVE IN OUR COMMUNITY. THEIR INITIATIVES ARE FOCUSED IN THOSE AREAS WHICH DIRECTLY IMPACT ECONOMIC GROWTH AND OPPORTUNITY, INCLUDING HUMAN CAPITAL DEVELOPMENT, INDUSTRY DEVELOPMENT, AND PUBLIC SAFETY. ST. JUDE ALSO PARTICIPATES WITH MEMPHIS FAST FORWARD WHOSE STRATEGIES ARE BASED ON THE PREMISE THAT ECONOMIC GROWTH AND PROSPERITY, AND IMPROVED QUALITY OF LIFE, WILL FOLLOW ONCE MEMPHIS AND SHELBY COUNTY SUCCESSFULLY ADDRESS THE BASICS: GOOD JOBS, QUALITY EDUCATION, SAFE STREETS AND EFFICIENT GOVERNMENT.AS ST. JUDE CONSIDERS THE NEXT GENERATION OF MEDICAL AND SCIENTIFIC PROFESSIONALS, IT IS INCUMBENT TO SUPPORT PROGRAMS TO IMPROVE ACCESS TO HEALTH CARE SERVICES. THE PEDIATRIC ONCOLOGY EDUCATION (POE) PROGRAM BROUGHT IN NEARLY 40 SUMMER STUDENTS FOR INTERNSHIPS IN BASIC SCIENCE OR CLINICAL RESEARCH. THE RHODES COLLEGE SUMMER PLUS PROGRAM ACCEPTS 15 STUDENTS INTO ST. JUDE RESEARCH LABORATORIES FOR A PERIOD OF ONE SUMMER, ONE ACADEMIC YEAR, AND A SECOND SUMMER. ST. JUDE EXPANDED THE AFTER SCHOOL STEM CLUB TO 26 AREA SCHOOLS. THESE PROGRAMS SUPPORT INCREASING THE AWARENESS OF CAREERS IN RESEARCH SCIENCE, HEALTHCARE, OR HEALTHCARE MANAGEMENT AND CONTRIBUTE TO PREPARING STUDENTS TO ENTER THESE CAREERS. THE CLINICAL EDUCATION AND TRAINING OFFICE HOSTS APPROXIMATELY 50 MEDICAL STUDENTS ANNUALLY FOR PATIENT CARE SHADOWING AND ROTATION EXPERIENCES. THIS PROGRAM HELPS PARTICIPANTS DETERMINE THEIR CAREER IN MEDICINE ACROSS THE FIELDS OF ONCOLOGY, HEMATOLOGY, AND INFECTIOUS DISEASES. ST. JUDE OFFERS EXPERIENTIAL LEARNING INTERNSHIPS ACROSS MANY AREAS FROM SCIENCE TO LEGAL, INFORMATION SERVICES, HUMAN RESOURCES, COMMUNICATION AND ACCOUNTING. PART III, LINE 2: BAD DEBT EXPENSE IS EQUAL TO CHARGES ON ACCOUNTS DETERMINED TO BE UNCOLLECTIBLE.THERE WERE NO UNCOLLECTIBLE ACCOUNTS IN THE CURRENT YEAR.ST. JUDE DOES NOT BILL PATIENTS OR PATIENT FAMILIES. PART III, LINE 3: ALL PATIENTS ARE ELIGIBLE FOR FINANCIAL ASSISTANCE UNDER THE FINANCIAL ASSISTANCE POLICY. THERE WAS NO BAD DEBT EXPENSE ATTRIBUTABLE TO PATIENTS UNDER THE FINANCIAL ASSISTANCE POLICY. ST. JUDE CHILDREN'S RESEARCH HOSPITAL DOES NOT CONSIDER BAD DEBT EXPENSE A COMMUNITY BENEFIT. PART III, LINE 4: NET PATIENT SERVICE REVENUES - NET OPERATING REVENUES ARE RECORDED AT THE TRANSACTION PRICE ESTIMATED BY THE HOSPITAL TO REFLECT THE TOTAL CONSIDERATION DUE FROM THIRD-PARTY PAYORS IN EXCHANGE FOR PROVIDING GOODS AND SERVICES IN PATIENT CARE. THESE SERVICES ARE CONSIDERED TO BE A SINGLE PERFORMANCE OBLIGATION AND HAVE A DURATION OF LESS THAN ONE YEAR. REVENUES ARE RECORDED AS THESE GOODS AND SERVICES ARE PROVIDED. THE TRANSACTION PRICE, WHICH INVOLVES SIGNIFICANT ESTIMATES, IS DETERMINED BASED ON THE HOSPITAL'S STANDARD CHARGES FOR THE GOODS AND SERVICES PROVIDED, WITH A REDUCTION RECORDED FOR PRICE CONCESSIONS RELATED TO THIRD PARTY CONTRACTUAL ARRANGEMENTS AS WELL AS OTHER IMPLICIT PRICE CONCESSIONS. PART III, LINE 8: ST. JUDE CHILDREN'S RESEARCH HOSPITAL DOES NOT CONSIDER THE MEDICARE SHORTFALL A COMMUNITY BENEFIT. THE COST TO CHARGE RATIO WAS USED TO DETERMINE MEDICARE ALLOWABLE COSTS OF CARE. PART III, LINE 9B: ALL PATIENTS ACCEPTED FOR ST. JUDE TREATMENT RECEIVE CARE WHETHER OR NOT THEY OR THEIR FAMILIES CAN PAY FOR IT. ST. JUDE DOES HAVE A BILLING SYSTEM, BUT PATIENTS DO NOT RECEIVE BILLS. IF THE PATIENT HAS INSURANCE, ST. JUDE BILLS THE INSURANCE PLAN OR OTHER ORGANIZATION THAT PAYS HEALTH COSTS. THIS IS SET FORTH IN OUR FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/ LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML). PART VI, LINE 2: ASSESSING THE HEALTHCARE NEEDS OF THE COMMUNITY IS A CRITICAL PRIORITY FOR ST. JUDE, INFLUENCING SERVICES, OUTREACH PROGRAMS, AND ADVOCACY INITIATIVES. ST. JUDE EMPLOYS COMPREHENSIVE METHODOLOGIES TO UNDERSTAND THE HEALTH REQUIREMENTS OF OUR POPULATION. THESE CATEGORIES ENCOMPASS A WIDE SPECTRUM, INCLUDING DEMOGRAPHIC ANALYSIS, EPIDEMIOLOGICAL STUDIES, COMMUNITY ENGAGEMENT, HEALTH DISPARITIES EVALUATION, AND COLLABORATION WITH PUBLIC HEALTH AGENCIES. BY STRATEGICALLY EVALUATING THESE ASPECTS, ST. JUDE GAINS CRUCIAL INSIGHTS INTO THE SPECIFIC HEALTH CHALLENGES, CULTURAL CONSIDERATIONS, AND SOCIAL DETERMINANTS IMPACTING THE COMMUNITY, ENABLING US TO EFFECTIVELY TAILOR SERVICES AND ADVOCACY EFFORTS.CANCERPEDIATRIC CANCERS ARE RARE COMPARED TO ADULT CANCERS. ABOUT 16,000 NEW CASES ARE EXPECTED TO OCCUR AMONG CHILDREN AND ADOLESCENTS AGES 0-19 IN CALENDAR YEAR 2024 IN THE U.S. WITH OVER 400,000 GLOBALLY. CANCER IS THE LEADING CAUSE OF DISEASE-RELATED DEATH IN U.S. CHILDREN. THE PRINCIPAL FOCUS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS CANCER. SEVENTY-FIVE PERCENT OF ALL RESOURCES AT ST. JUDE ARE INVESTED IN ELUCIDATING BASIC BIOLOGICAL MECHANISMS OF PEDIATRIC CANCERS AND TRANSLATING THIS KNOWLEDGE INTO IMPROVED DIAGNOSTIC TOOLS AND CURATIVE THERAPIES, WHILE MINIMIZING LONG-TERM SIDE EFFECTS. AS THE FIRST AND ONLY NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER FOCUSED EXCLUSIVELY ON CHILDREN, ST. JUDE SERVES AS A NATIONAL RESOURCE FOR RESEARCH AND TREATMENT OF PEDIATRIC CANCERS. OUR INITIATIVES ARE DESIGNED TO IMPACT PEDIATRIC CANCER TREATMENT ON A LOCAL, REGIONAL, NATIONAL AND GLOBAL SCALE.THERE ARE NO KNOWN DIFFERENCES IN PEDIATRIC CANCER INCIDENCE BY GEOGRAPHIC REGION IN THE U.S. CONSEQUENTLY, IT IS NOT POSSIBLE TO CATER OUR CLINICAL TRIALS TO TARGET PEDIATRIC CANCERS SPECIFICALLY PREVALENT IN OUR CATCHMENT AREA. OUR RESEARCH AND CLINICAL TRIALS ADDRESS THE MOST PRESSING PROBLEMS IN PEDIATRIC CANCER. ST. JUDE OFFERS THERAPEUTIC TRIALS FOR THE TOP PEDIATRIC CANCERS, INCLUDING ACUTE LYMPHOBLASTIC LEUKEMIA, MEDULLOBLASTOMA, NEUROBLASTOMA, HODGKIN LYMPHOMA, RETINOBLASTOMA, RHABDOMYOSARCOMA AND OTHERS. MANY OF THESE TRIALS ARE INSTITUTIONALLY SPONSORED; HOWEVER, ST. JUDE ALSO PARTICIPATES IN SEVERAL CLINICAL TRIALS CONSORTIA PROVIDING OUR CANCER PATIENTS ACCESS TO A VARIETY OF THERAPEUTIC STUDIES. PEDIATRIC CANCER PATIENTS MAY EXPERIENCE TREATMENT-RELATED SIDE EFFECTS MANY YEARS AFTER DIAGNOSIS. THE CHILDHOOD CANCER SURVIVOR STUDY AND ST. JUDE LIFE ARE TWO ACTIVE STUDIES, ASSESSING LATE EFFECTS OF CANCER THERAPY ON PEDIATRIC CANCER SURVIVORS. INFORMATION FROM THESE STUDIES IS USED TO DEFINE RISK GROUPS FOR VARIOUS LATE EFFECTS AND ASSESS INTERVENTIONS. COMMUNITY OUTREACH AND ENGAGEMENT (COE) AT THE ST. JUDE COMPREHENSIVE CANCER CENTER (SJCCC) PROMOTES A COORDINATED APPROACH TO ENSURING THAT CHILDREN WHO HAVE CANCER, CHILDREN WHO HAVE SURVIVED CANCER, AND HEALTHY CHILDREN ALL BENEFIT FROM CUTTING-EDGE SCIENCE, CLINICAL CARE, AND PREVENTION EFFORTS PROVIDED BY THE SJCCC. THESE COE ACTIVITIES SPAN LOCAL, NATIONAL, AND GLOBAL GEOGRAPHIC AREAS THROUGH THE COLLECTIVE IMPACT OF THE ST. JUDE HPV CANCER PREVENTION PROGRAM, CANCER EDUCATION AND OUTREACH PROGRAM IN SCHOOLS, TOGETHER WEBSITE, ST. JUDE AFFILIATE NETWORK, AND THE ST. JUDE GLOBAL PEDIATRIC MEDICINE PROGRAM. THE ST. JUDE PATIENT FAMILY ADVISORY COUNCIL (PFAC) PROVIDES THE OPPORTUNITY FOR COE TO ENGAGE PATIENTS AND FAMILIES. A MEMBER OF THE COE LEADERSHIP TEAM IS ACTIVE IN THE PFAC AS A STAFF CHAMPION, ATTENDS MONTHLY MEETINGS, FACILITATES CONNECTIONS, AND SUPPORTS COMMUNICATION BETWEEN THE PFAC AND THE COE. THE HEALTHY CHILDREN ADVISORY COUNCIL MEANINGFULLY ENGAGES REPRESENTATIVES OF COMMUNITIES SERVED BY THE COMPREHENSIVE CANCER CENTER TO FUNCTION IN AN ADVISORY CAPACITY, SUCH AS BY PROVIDING ADVICE ON IDENTIFYING, PRIORITIZING, AND COMMUNICATING NEEDS ACROSS THE SJCCC AND TO COMMUNITIES. HEMATOLOGYMORE THAN 100,000 PEOPLE IN THE UNITED STATES HAVE SICKLE CELL DISEASE (SCD), AND IT IS ESTIMATED THAT MORE THAN 1 MILLION PEOPLE WORLDWIDE SUFFER FROM THE DISEASE. IT IS THE MOST FREQUENT GENETIC BLOOD DISORDER IN THE WORLD. ST. JUDE HAS ONE OF THE LARGEST PEDIATRIC SCD PROGRAMS IN THE COUNTRY AND PROVIDES COMPREHENSIVE TREATMENT AND EDUCATION TO ABOUT 900 CHILDREN WITH SCD IN THE GEOGRAPHIC CATCHMENT AREA. SCD IS DIAGNOSED BY STATE-WIDE NEWBORN SCREENING IN ALL 50 STATES. ST. JUDE HAS A PARTNERSHIP WITH NEWBORN SCREENING PROGRAMS IN TN AND MS THAT ENSURES A STABLE RELATIONSHIP AMONG PARENTS, PATIENTS, AND PRIMARY CARE PROVIDERS. ABOUT 50 NEWBORNS WITH SCD ARE IDENTIFIED EACH YEAR IN OUR GEOGRAPHIC CATCHMENT AREA. OUR SCD INFANT TODDLER PROGRAM CONTACTS AND ACCEPTS ALL CHILDREN DIAGNOSED WITH THE DISEASE IN OUR CATCHMENT AREA TO ITS COMPREHENSIVE CARE SERVICE. ADDITIONALLY, ST. JUDE PROVIDES TRAIT COUNSELING SERVICE TO INFANTS BORN WITH SICKLE CELL TRAIT TO 21 COUNTIES IN WESTERN TN. ST. JUDE PROVIDES CONFIRMATORY TESTING, EDUCATION AND COMPREHENSIVE CARE AND FOLLOW-UP THROUGHOUT CHILDHOOD FOR CHILDREN WITH SCD DISEASE. FROM BIRTH TO AGE 18 YEARS, PATIENTS ARE CLINICALLY EVALUATED AT LEAST EVERY 6 MONTHS, RECEIVE EDUCATION AND MULTI-DISCIPLINARY SERVICES ACCORDING TO STANDARDIZED TREATMENT AND EDUCATION GUIDELINES. SERVICES ALSO INCLUDE COMMUNITY OUTREACH AND EDUCATION OF THE LOCAL COMMUNITY. ST. JUDE HAS ESTABLISHED A FORMAL TRANSITION PROGRAM TO ADULT CARE FOR PATIENTS WITH SCD AND PROVIDES SUPPORT TO PATIENTS AND FAMILIES THROUGHOUT THE TRANSITION PROCESS BY WORKING CLOSELY WITH THE ADULT SCD PROGRAMS AT METHODIST UNIVERSITY HOSPITAL AND REGIONAL ONE HOSPITAL. ST. JUDE ALSO PROVIDES CLINICAL SERVICES FOR APPROXIMATELY 800 CHILDREN PER YEAR WITH OTHER NON-MALIGNANT HEMATOLOGICAL DISORDERS THROUGH A STRONG RELATIONSHIP WITH LOCAL COMMUNITY PHYSICIANS. CHILDREN FROM THE GEOGRAPHIC CATCHMENT AREA OF ST. JUDE WITH ILLNESSES SUCH AS HEMOPHILIA, APLASTIC ANEMIA, THROMBOSIS, THALASSEMIA, SPHEROCYTOSIS, AND IMMUNE THROMBOCYTOPENIC PURPURA AND OTHER NON-MALIGNANT HEMATOLOGIC DISORDERS ARE REFERRED TO AND RECEIVE STATE-OF THE-ART CARE FROM ST. JUDE PHYSICIANS AND MEDICAL STAFF.ST. JUDE IS ONE OF A SELECT GROUP OF FEDERALLY RECOGNIZED PEDIATRIC HEMOPHILIA TREATMENT CENTERS AND PROVIDES STATE-OF-THE-ART COMPREHENSIVE CARE TO APPROXIMATELY 300 CHILDREN WITH BLEEDING AND THROMBOSIS DISORDERS. IN ADDITION TO PROVIDING AND CONTINUOUSLY IMPROVING STANDARDIZED CARE TO THESE PATIENT POPULATIONS, ST. JUDE HEMATOLOGY DEDICATES SIGNIFICANT RESOURCES TO CLINICAL, TRANSLATIONAL, AND BASIC RESEARCH TO IMPROVE SURVIVAL AND DECREASE MORBIDITY OF CHILDREN WITH NON-MALIGNANT CHRONIC BLOOD DISEASES. MOST PATIENTS PARTICIPATE IN RESEARCH STUDIES, WHICH HAVE RESULTED IN MAJOR IMPROVEMENTS IN CLINICAL CARE. ST. JUDE IS PARTNERING WITH SEVERAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO PROVIDE ACCESS TO FIRST-IN-HUMAN GENETIC THERAPIES FOR SCD. ST. JUDE IS ALSO DEVELOPING SEVERAL NOVEL GENETIC THERAPIES TO CURE SCD. IN ADDITION, AN ONGOING CLINICAL TRIAL IS EVALUATING A NEW METHOD OF BONE MARROW TRANSPLANTATION FOR PATIENTS WITH SICKLE CELL DISEASE.HIVTHE CONNECT TO PROTECT (C2P) COMMUNITY COALITION LED BY MEMBERS OF THE HOSPITAL'S COMPREHENSIVE HIV PREVENTION AND TREATMENT PROGRAM FOR CHILDREN AND YOUTH, HAS SIGNIFICANTLY CONTRIBUTED TO THE STRONG COMMUNITY TIES THAT ST. JUDE HAS ESTABLISHED AND STRENGTHENED. LAUNCHED IN 2008, C2P IS MADE UP OF 25 PARTNER AGENCIES REPRESENTING A DIVERSE MIX OF STAKEHOLDERS FROM VARIOUS SECTORS IN MEMPHIS. THIS INCLUDES THE HEALTH DEPARTMENT, FAITH-AND COMMUNITY-BASED ORGANIZATIONS, SCHOOLS, BUSINESSES, YOUTH, AND HEALTH CARE ORGANIZATIONS; ALL ALIGNED WITH THE COMMON GOAL OF OPTIMIZING HIV PREVENTION AND TREATMENT. THE STRENGTH OF THIS COALITION HAS BEEN TO PROVIDE A NON-THREATENING, COLLABORATIVE ENVIRONMENT WHERE INDIVIDUALS AND AGENCIES WITH DIFFERENT BACKGROUNDS AND PRIORITIES HAVE BEEN ABLE TO COLLABORATIVELY IMPLEMENT NEW POLICIES, PRACTICES AND PROGRAMS THAT IMPACT HIV PREVENTION AND TREATMENT IN YOUTH. PART VI, LINE 3: NO FAMILY EVER PAYS ST. JUDE FOR TREATMENT. IN ADDITION, ST. JUDE PROVIDES AN UNPARALLELED LEVEL OF SUPPORT SERVICES AT NO COST TO FAMILIES. WE ALSO HAVE PROGRAMS TO ASSIST FAMILIES IN ENROLLING IN VARIOUS PUBLIC ASSISTANCE PROGRAMS FOR WHICH THEY MAY QUALIFY, INCLUDING BUT NOT LIMITED TO TENNCARE/MEDICAID, COVERKIDS, CHIPS AND SOCIAL SECURITY. FAMILIES ALSO HAVE ACCESS TO AN ONLINE EDUCATIONAL RESOURCE TITLED "GETTING INSURANCE THROUGH THE HEALTH INSURANCE MARKETPLACE" AT THIS LINK: HTTPS://TOGETHER.STJUDE.ORG/EN-US/FOR-FAMILIES/NAVIGATING-HEALTH-CARE/AFFORDABLE-CARE-ACT.HTML. THIS ENSURES AN APPROPRIATE SAFETY NET SHOULD THE FAMILY SEEK TREATMENT OUTSIDE OF ST. JUDE AND IT ALLOWS US TO BE GOOD STEWARDS OF DONOR DOLLARS. WE UTILIZE AN OUTSIDE CONTRACTOR TO PROVIDE APPLICATION ASSISTANCE. THE HOSPITAL'S FINANCIAL ASSISTANCE STATEMENT (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-STATEMENT.HTML) AND FINANCIAL ASSISTANCE POLICY (HTTPS://WWW.STJUDE.ORG/LEGAL/FINANCIAL-ASSISTANCE-POLICY.HTML) ARE POSTED ON THE HOSPITAL'S WEBSITE AND AVAILABLE AT REGISTRATION. THE DOCUMENTS ARE AVAILABLE IN ENGLISH AND SPANISH. FOR FAMILIES SPEAKING OTHER LANGUAGES, WE UTILIZE ONSITE INTERPRETER SERVICES AND/OR PROFESSIONAL CONTRACTED INTERPRETATION AND TRANSLATION SERVICES. PART VI, LINE 4: THE COMMUNITY SERVED BY ST. JUDE CAN BEST BE DEFINED THROUGH THE CATCHMENT AREA, WHICH INCLUDES A 180-MILE RADIUS FROM MEMPHIS, TN, AS WELL AS 100-MILE RADIUS FROM THE 8 AFFILIATE LOCATIONS. ADDITIONALLY, ST. JUDE SERVES AS A NATIONAL REFERRAL CENTER FOR CHILDREN WITH CATASTROPHIC DISEASES. THE LOCAL REFERRAL CENTER IS FOR CHILDREN WITH CANCER, BLOOD DISORDERS, HIV/AIDS, AND NEUROLOGICAL DISORDERS. IT DOES NOT ADMIT CHILDREN FOR ANY DIAGNOSES OUTSIDE OF THESE AREAS AND DOES NOT OFFER MEDICAL SERVICES BEYOND THOSE NECESSARY TO CARE FOR CHILDREN WITH THESE DISEASES.OUR CANCER PATIENTS COME FROM ALL OVER THE UNITED STATES AND ABROAD; HOWEVER, 65% OF THE NEW CANCER PATIENTS WE REGISTER RESIDE IN THE ST. JUDE CATCHMENT AREA. THE EIGHT AFFILIATES ARE IN HUNTSVILLE, AL, CHARLOTTE, NC, JOHNSON CITY, TN, BATON ROUGE, LA, SHREVEPORT, LA, TULSA, OK, SPRINGFIELD, MO, AND PEORIA, IL. THROUGH ST. JUDE'S FOUNDING PHILOSOPHY THAT NO PATIENT BE DENIED TREATMENT BASED ON RACE, ETHNICITY, RELIGION, OR A FAMILY'S INABILITY TO PAY AND WITH THE PROVISION OF RESOURCES TO OFFSET THE COSTS OF TRANSPORTATION AND HOUSING DURING CLINIC VISITS AND TREATMENT, WE REMOVE BARRIERS IN ACCESS TO OUR CUTTING-EDGE CLINICAL RESEARCH TRIALS AND EXCEPTIONAL CLINICAL CARE. ALL PEDIATRIC PATIENTS IN OUR CATCHMENT AREA ARE ACCEPTED TO ST. JUDE FOR TREATMENT OF THEIR CANCER. THE DEMOGRAPHICS OF THE PEDIATRIC CANCER POPULATION TREATED AT ST. JUDE CLOSELY MATCH THOSE OF OUR CATCHMENT AREA (BASED ON 2010 DATA FROM THE US CENSUS BUREAU) AND ALIGN WITH THE ESTIMATED INCIDENCE OF PEDIATRIC CANCER IN REPRESENTED RACIAL AND ETHNIC GROUPS (BASED ON SURVEILLANCE EPIDEMIOLOGY AND END RESULTS [SEER] 2009 DATA), CONFIRMING THAT ST. JUDE IS CLOSELY ALIGNED WITH THE NEEDS OF THE POPULATION IT SERVES.ST. JUDE ALSO OPERATES THE ST. JUDE GLOBAL INITIATIVE THROUGH GLOBAL PEDIATRIC MEDICINE (GPM), AIMED AT IMPROVING SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE. ST. JUDE ACCOMPLISHES THIS BY SHARING KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS, IMPLEMENTING NEW APPROACHES TO TREAT PEDIATRIC CANCER GLOBALLY, AND GENERATING INTERNATIONAL NETWORKS COMMITTED TO ERADICATING CANCER IN CHILDREN. ST. JUDE STRIVES TO ADDRESS THE NEEDS OF THOSE CHILDREN IN COUNTRIES THAT LACK SUFFICIENT RESOURCES AND HELP THEM MANAGE THEIR OWN BURDEN OF CASES EFFECTIVELY.THE ST. JUDE GLOBAL ALLIANCE IS A GLOBAL NETWORK ESTABLISHED TO PURSUE THE SHARED VISION OF IMPROVING THE QUALITY OF HEALTH CARE DELIVERY AND INCREASING SURVIVAL RATES OF CHILDREN WITH CANCER AND BLOOD DISORDERS WORLDWIDE. CURRENTLY, THE ALLIANCE ESTABLISHED PARTNERSHIPS WITH OVER 300 MEDICAL INSTITUTIONS AND FOUNDATIONS IN MORE THAN 80 COUNTRIES. MEMBERS OF THE ALLIANCE ARE A PART OF A GLOBAL COMMUNITY DEDICATED TO TRANSFORMING GLOBAL CHILD HEALTH. THEY WILL HAVE THE OPPORTUNITY TO DEVELOP GLOBAL PROJECTS AND STUDIES, CONNECT WITH COMMITTEES AND WORKING GROUPS AT THE REGIONAL AND GLOBAL LEVEL, AND ENGAGE WITH ST. JUDE FACULTY AND STAFF FOR TRAINING AND DEVELOPMENT. THE ST. JUDE GLOBAL ALLIANCE INCLUDES MEMBER INSTITUTIONS IN THE FOLLOWING REGIONS: CENTRAL AMERICA AND THE CARIBBEAN, EAST ASIA AND THE PACIFIC, EUROPE, MIDDLE EAST AND NORTH AFRICA, NORTH AMERICA, EASTERN EUROPE AND NEIGHBORING STATES, SOUTH AMERICA, SOUTH ASIA, AND SUB-SAHARAN AFRICA. PART VI, LINE 5: INSTITUTION OPERATIONS ARE OVERSEEN BY A BOARD OF GOVERNORS, MOST OF WHICH ARE NEITHER EMPLOYEES, INDEPENDENT CONTRACTORS, NOR THEIR FAMILY MEMBERS. RESEARCH ACTIVITIES ARE REVIEWED ANNUALLY BY A SCIENTIFIC ADVISORY BOARD COMPOSED OF INTERNATIONALLY PROMINENT PHYSICIANS AND SCIENTISTS. AN INSTITUTIONAL REVIEW BOARD (IRB), WHICH IS A GROUP OF SCIENTISTS, DOCTORS, OR OTHER HEALTH CARE PROFESSIONALS, REVIEWS AND APPROVES EVERY NEW CLINICAL RESEARCH STUDY AT THE HOSPITAL BEFORE IT BEGINS. THE PRIMARY FUNDRAISING SOURCE FOR ST. JUDE IS ALSAC (AMERICAN LEBANESE AND SYRIAN ASSOCIATED CHARITIES), WHICH RAISES FUNDS SOLELY FOR THE HOSPITAL. BECAUSE OF THE HOSPITAL'S MISSION, PEOPLE NATIONWIDE CONTRIBUTE VIA TENS OF THOUSANDS OF FUNDRAISING EFFORTS. ALSAC CONTRIBUTED $1.68 BILLION IN FY24 TO SUPPORT ST. JUDE. FINDING CURES AND SAVING CHILDREN REMAINS AT THE FOREFRONT OF ALL WE DO. WE CARE FOR THOUSANDS OF CHILDREN WITH CANCER AND OTHER LIFE-THREATENING DISEASES. WE ARE FOCUSED ON ENSURING PATIENTS RECEIVE THE TREATMENT THEY NEED, AND UNDERSTANDING THE SCIENTIFIC FOUNDATION THROUGH BASIC AND TRANSLATIONAL RESEARCH, CLINICAL TRIALS, AND POPULATION SCIENCE FOCUSED ON CATASTROPHIC CHILDHOOD DISEASES AND SURVIVORSHIP.ST. JUDE IS IN YEAR FOUR OF A SIX-YEAR STRATEGIC PLAN THAT WILL COMMIT $12.9 BILLION TO SUPPORT 2,300 ADDITIONAL JOBS AND INCREASE FUNDS FOR CONSTRUCTION, RENOVATION AND CAPITAL NEEDS. THE PLAN IMPACTS SCIENTIFIC OPERATIONS, CLINICAL CARE, GLOBAL MEDICINE, AND INFRASTRUCTURE. THE PLAN INCLUDES CONSTRUCTION OF TWO, 15-STORY TOWERS DEDICATED TO PATIENT CARE AND CLINICAL RESEARCH. IN 2023, ST. JUDE OPENED A NEW HOUSING COMPLEX AS WELL AS A TREATMENT-AND-STAFF-FREE FLOOR AT THE HOSPITAL WHERE PATIENTS AND THEIR FAMILIES CAN GATHER, RELAX, ATTEND SCHOOL, PLAY MUSIC, NAP, OR GRAB A CUP OF COFFEE IN BETWEEN CLINIC APPOINTMENTS. ST. JUDE AND THE MEMPHIS-SHELBY COUNTY AIRPORT AUTHORITY OFFER A ONE-OF-ITS KIND PRIVATE, COMFORTABLE SPACE FOR PATIENTS AND THEIR FAMILIES TO WAIT FOR THEIR FLIGHT OR TRANSPORTATION TO THE CAMPUS.ST. JUDE USES THE SERVICES OF CHILDREN'S GMP, LLC (OF WHICH ST. JUDE IS THE SOLE MEMBER). CHILDREN'S GMP, LLC, MANAGES AND OPERATES A GOOD MANUFACTURING PRACTICE (GMP) FACILITY THAT ENGAGES IN THE PRODUCTION OF BIOLOGICS AND DRUGS FOR RESEARCH. THE GMP OFFERS RESOURCES TO STUDY RARE DISEASES OVERLOOKED BY PHARMACEUTICAL COMPANIES BECAUSE THERE IS LITTLE PROFIT IN MANUFACTURING DRUGS FOR VERY RARE DISEASES. THE FACILITY, OPERATING ACCORDING TO APPROVED FDA STANDARDS, ALLOWS DOCTORS TO TAILOR TREATMENTS SPECIFICALLY FOR AN INDIVIDUAL CHILD.ST. JUDE IS HOME TO A PROTON BEAN THERAPY CENTER DEVOTED SOLELY TO TREATING CHILDREN WITH BRAIN TUMORS AND SEVERAL OTHER CHILDHOOD CANCERS. PROTON THERAPY, WHICH IS LESS DAMAGING TO SURROUNDING HEALTHY TISSUE THAN OTHER CURRENT RADIATION THERAPIES, ENABLES ST. JUDE TO PROVIDE RADIATION IN A MORE INTEGRATED MANNER TO OUTPATIENTS AND ALLOWS RADIATION ONCOLOGISTS TO LEAD THE DEVELOPMENT OF NEW TREATMENTS.IN CALENDAR YEAR 2023, ST. JUDE FACULTY AND STAFF WERE FIRST, LAST, SENIOR, OR CORRESPONDING ON 105 PUBLISHED SCIENTIFIC PAPERS WITH AN IMPACT FACTOR GREATER THAN 10 (HIGH IMPACT PUBLICATIONS). THE ARTICLES FOCUSED ON A BROAD SWATH OF BASIC AND CLINICAL RESEARCH. PRESS RELEASES FOR THE MOST IMPACTFUL DISCOVERIES CAN BE FOUND AT HTTPS://WWW.STJUDE.ORG/MEDIA-RESOURCES.HTML.GLOBALST. JUDE GLOBAL INITIATIVES FINANCIAL SUPPORT WILL GROW TO $100 MILLION ANNUALLY BY 2024 TO FURTHER ENHANCE ST. JUDE-ESTABLISHED NETWORKS AROUND THE WORLD. BY TRAINING DOCTORS, NURSES, RESEARCHERS AND OTHER PROFESSIONALS; DEVELOPING AND STRENGTHENING HEALTH CARE SYSTEMS; AND ADVANCING KNOWLEDGE TO SUSTAIN IMPROVEMENTS IN HOW MEDICINE IS PRACTICED INTERNATIONALLY, THE INSTITUTION SEEKS TO INCREASE CURE RATES TO 60% OF CHILDREN WITH SIX OF THE MOST COMMON CHILDHOOD CANCERS WORLDWIDE DURING THE NEXT DECADE.COMMUNITY PROGRAMS AND OUTREACHST. JUDE PLAYS AN IMPORTANT ROLE IN HELPING THE COMMUNITY WHETHER IT'S THROUGH MISSION-ORIENTED HEALTH PROGRAMS, GENERAL STEM EDUCATION PROGRAMS OR PUBLIC HEALTH CAMPAIGNS.TO HELP EXPAND RESEARCH AND CLINICAL CARE FOR ADULT SICKLE CELL PATIENTS IN MEMPHIS, ST. JUDE, WHICH HAS ONE OF THE LARGEST PEDIATRIC SICKLE CELL PROGRAMS IN THE COUNTRY, HAS COLLABORATED WITH METHODIST UNIVERSITY HOSPITAL TO HELP YOUNG ADULTS, AGES 18 AND OLDER, MANY OF WHOM RECEIVED CARE AS PEDIATRIC PATIENTS AT ST. JUDE, LEARN HOW TO MAKE THEIR OWN TREATMENT DECISIONS AS ADULTS. ADDITIONALLY, ST. JUDE HAS ESTABLISHED A REMOTE TELEHEALTH HEMATOLOGY CLINIC IN NORTH MISSISSIPPI TO INCREASE ACCESS TO CARE FOR PATIENTS IN THAT REGION WITH LIMITED ACCESS TO HEMATOLOGY SERVICES. THE ST. JUDE HPV CANCER PREVENTION PROGRAM LAUNCHED A PUBLIC AWARENESS CAMPAIGN TO BRING MORE ATTENTION TO THE NEED FOR AND BENEFITS OF ADOLESCENTS AGES 9-12 RECEIVING ON-TIME HUMAN PAPILLOMAVIRUS (HPV) VACCINATION TO PREVENT CANCER.VIA THE CONNECT2PROTECT PROGRAM, ST. JUDE COLLABORATES WITH CHURCHES, OTHER HEALTH CARE ORGANIZATIONS AND CIVIC GROUPS TO RAISE AWARENESS ABOUT PREVENTING THE SPREAD OF HIV/AIDS. THE PRIMARY TARGET IS THE AFRICAN-AMERICAN COMMUNITY, ALTHOUGH OTHER ETHNIC GROUPS ARE ALSO SERVED, INCLUDING ASIAN, CAUCASIAN AND HISPANIC.ST. JUDE FOCUSES ON EDUCATING AND TRAINING THE NEXT GENERATION OF DOCTORS, NURSES, RESEARCHERS AND ACADEMIC LEADERS. FROM HIGH SCHOOL STUDENTS TO THE POSTDOCTORAL LEVEL, THE HOSPITAL PLAYS A MAJOR ROLE IN PREPARING FUTURE LEADERS OF SCIENCE AND MEDICINE THROUGH OUR K-12 EDUCATION OUTREACH, INCLUDING CANCER EDUCATION AT HOME/CLASSROOM KITS, ST. JUDE AFTERSCHOOL STEM CLUBS, ST. JUDE COMMUNITY HEALTH CLUBS, BIOSTEM IN CANCER EDUCATION COLLABORATIVE, VIRTUAL SCIENCE JOURNAL CLUBS,AND A HIGH SCHOOL AND COLLEGE RESEARCH IMMERSION (HRSI)PROGRAM; PLUS OUR POST-SECONDARY PROGRAMS, INCLUDING THE PEDIATRIC ONCOLOGY EDUCATION (POE) PROGRAM FOR UNDERGRADUATE STUDENTS, ST. JUDE GRADUATE SCHOOL FOR MASTER'S AND PHD DEGREES; NURSING EXTERNSHIP PROGRAMS FOR NEW NURSES; AND NUMEROUS POST-DOCTORAL AND CLINICAL FELLOWSHIP OPPORTUNITIES.FURTHERMORE, ST. JUDE PROVIDES ONLINE EDUCATION AND COLLABORATION OPPORTUNITIES FOR CLINICAL AND PATIENT FAMILY EDUCATION. ST. JUDE GLOBAL OFFERS A WEB SITE, CURE4KIDSTM (WWW.CURE4KIDS.ORG), TO HELP TRAIN CLINICAL STAFF AROUND THE WORLD. THE TOGETHER WEBSITE (TOGETHER.STJUDE.ORG), A PATIENT EDUCATION RESOURCE FOR ANYONE AFFECTED BY CHILDHOOD AND ADOLESCENT CANCER AND OTHER CATASTROPHIC DISEASES IS AVAILABLE IN 12 LANGUAGES: ARABIC, BURMESE, CHINESE (SIMPLIFIED), FRENCH, HINDI, POLISH, PORTUGUESE, RUSSIAN, SPANISH, UKRAINIAN AND URDU. THE TOGETHER TEENS & 20S MINI-SITE OFFERS ADOLESCENT AND YOUNG ADULT CANCER PATIENTS AND SURVIVORS AGES 13-25 YEARS INFORMATION SPECIFIC TO THEIR STAGE OF LIFE.LASTLY, THE INSTITUTION VALUES ITS COMMUNITY VOLUNTEER PROGRAM WHICH ENHANCES THE QUALITY OF PATIENT CARE BY PARTNERING VOLUNTEERS WITH CLINICAL STAFF TO PROVIDE AN ADDITIONAL PERSONAL TOUCH. THEY LEND ASSISTANCE AND PROVIDE COMPASSIONATE CONCERN BY OFFERING A LISTENING EAR TO FAMILIES AT A TIME WHEN THEY NEED IT MOST. THEY ARE VITAL AMBASSADORS FOR THE HOSPITAL AND COMMUNITY. 0 CHURCH HEALTH 1350 CONCOURSE AVENUE STE 142 MEMPHIS TN 38104 581716113 501(C)(3) 115000 0 FINANCIAL SUPPORT CHILDRENS HOSPITAL OF PHILADELPHIA 3401 CIVIC CENTER BLVD PHILADELPHIA PA 191044318 231352166 501(C)(3) 27000 0 SPONSORSHIP GORDON RESEARCH CONFERENCES 5586 POST ROAD UNIT 2 EAST GREENWICH RI 02818 260150662 501(C)(3) 20000 0 SPONSORSHIP BLUFF CITY MEDICAL SOCIETY PO BOX 17924 MEMPHIS TN 38187 931746107 501(C)(3) 20000 0 SPONSORSHIP HPV CANCERS ALLIANCE PO BOX 230575 NEW YORK NY 10023 841950434 501(C)(3) 13000 0 SPONSORSHIP THE UNIVERSITY OF TENNESSEE 62 SOUTH DUNLAP ST STE 500 MEMPHIS TN 38163 621844686 GOVERNMENTAL ENTITY 10000 0 SPONSORSHIP REGIONAL ONE HEALTHCARE FOUNDATION 877 JEFFERSON AVENUE MEMPHIS TN 38120 581737037 501(C)(3) 8000 0 SPONSORSHIP INTERNATIONAL SOCIETY FOR EXPERIMENTAL HEMATOLOGY PO BOX 778831 CHICAGO IL 606778831 237282003 501(C)(3) 7500 0 SPONSORSHIP NATIONAL CIVIL RIGHTS MUSEUM 450 MULBERRY ST MEMPHIS TN 381034214 581484027 501(C)(3) 6300 0 SPONSORSHIP INDIANA IMMUNIZATION COALITION INC 6919 E 10TH ST C-2 INDIANAPOLIS IN 46219 200484362 501(C)(3) 5500 0 SPONSORSHIP 10 10 PART I, LINE 2: ST. JUDE CHILDREN'S RESEARCH HOSPITAL PERFORMS DUE DILIGENCE IN THE SELECTION PROCESS FOR ORGANIZATIONS THAT RECEIVE FINANCIAL SUPPORT AND SPONSORSHIPS, AND THE INTENDED PURPOSE OF THESE FUNDS ARE OUTLINED TO ENSURE THE SUPPORT IS USED APPROPRIATELY. X 1 1 X X X X X 0 1 0 0 0 0 0 0 0 JAMES R DOWNING PRESIDENT/CEO 1489108 0 45250 0 834224 0 36300 0 29308 0 2434190 0 597000 0 RICHARD C SHADYAC JR EX-OFFICIO DIRECTOR 0 1246368 0 0 0 49146 0 140480 0 25793 0 1461787 0 40002 ELLIS NEUFELD EVP/CLINICAL DIRECTOR 924653 0 75250 0 251552 0 36300 0 31808 0 1319563 0 229738 0 MICHAEL DYER CHAIR 652748 0 110250 0 400150 0 36300 0 37925 0 1237373 0 0 0 CHARLES M ROBERTS EVP/DIRECTOR CANCER CENTER 978926 0 75250 0 24701 0 102980 0 23972 0 1205829 0 0 0 JOSEPH P TAYLOR EVP/SCIENTIFIC DIRECTOR 971012 0 250 0 2884 0 196352 0 22955 0 1193453 0 0 0 PATRICIA A KEEL EVP, CAO & CFO 776292 0 300250 0 9523 0 36300 0 23975 0 1146340 0 0 0 THOMAS E MERCHANT CHAIR 952668 0 250 0 115972 0 36300 0 40425 0 1145615 0 0 0 ANDREW DAVIDOFF CHAIR 923458 0 250 0 86971 0 36300 0 35711 0 1082690 0 0 0 CARLOS RODRIGUEZ-GALINDO EVP/CHAIR 815485 0 75250 0 5436 0 91784 0 13326 0 1001281 0 0 0 DAVID ELLISON CHAIR 887548 0 250 0 9475 0 36300 0 14226 0 947799 0 0 0 AMAR GAJJAR CHAIR 783717 0 10250 0 74779 0 36300 0 20598 0 925644 0 0 0 JAMES I MORGAN FORMER OFFICER 523763 0 250 0 7514 0 36300 0 31340 0 599167 0 0 0 PART I, LINE 1A TAX INDEMNIFICATION AND GROSS-UP PAYMENTS: A PAYMENT WAS ISSUED FOR DEPENDENT TUITION FOR TWO OFFICERS AND TWO HIGHEST COMPENSATED EMPLOYEES. THE APPLICABLE EXPENSE WAS GROSSED-UP AND INCLUDED IN THE EMPLOYEE'S W-2 AS ADDITIONAL TAXABLE COMPENSATION. PART I, LINE 4B: THE ORGANIZATION ESTABLISHED A NON-QUALIFIED DEFERRED COMPENSATION PLAN PURSUANT TO CODE SECTION 457(F) OF THE INTERNAL REVENUE CODE. THE PLAN AMOUNTS ARE SUBJECT TO SUBSTANTIAL FUTURE SERVICE REQUIREMENTS TO THE ORGANIZATION AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE. NONQUALIFIED PLAN DISTRIBUTIONS WERE MADE DURING THE YEAR TO THE FOLLOWING LISTED PERSONS IN PART VII: RICHARD C. SHADYAC, JR. $40,002 JAMES R. DOWNING $824,596 ELLIS NEUFELD $241,921 SCHEDULE J, PART II: RICHARD C. SHADYAC, JR. SERVES AS AN EX-OFFICIO VOTING DIRECTOR OF THE BOARD OF ST. JUDE. MR. SHADYAC IS EMPLOYED AS AN OFFICER OF ALSAC, A RELATED ORGANIZATION TO ST. JUDE. THE COMPENSATION SHOWN IN COLUMNS (B), (C), (D) AND (E) WAS PAID TO MR. SHADYAC BY ALSAC FOR HIS DUTIES AS CEO OF ALSAC. SUSANNA DOWNING SEE PART V 116164 EMPLOYMENT 0 MONDIRA KUNDU SEE PART V 503882 EMPLOYMENT 0 DIANE ROBERTS SEE PART V 352501 EMPLOYMENT 0 LYNN RODRIGUEZ SEE PART V 143784 EMPLOYMENT 0 SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: SUSANNA DOWNING(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF PRESIDENT AND CEO, JAMES R. DOWNING.(C) AMOUNT OF TRANSACTION: $116,164(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: MONDIRA KUNDU(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, JOSEPH P. TAYLOR.(C) AMOUNT OF TRANSACTION: $503,882(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: DIANE ROBERTS(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, CHARLES M. ROBERTS.(C) AMOUNT OF TRANSACTION: $352,501(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: LYNN RODRIGUEZ(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER, CARLOS RODRIGUEZ-GALINDO.(C) AMOUNT OF TRANSACTION: $143,784(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO FORM 990, PART VI, SECTION A, LINE 2 FAMILY RELATIONSHIP AMONG DIRECTORS: JOSEPH S. AYOUB, JR., ESQ. AND PAUL J. AYOUB, ESQ.; ROBERT A. BREIT, MD, AND JOSEPH G. SHAKER; JOSEPH C. SHAKER AND JOSEPH G. SHAKER. BUSINESS RELATIONSHIP AMONG DIRECTORS: JOSEPH C. SHAKER AND JOSEPH G. SHAKER. FORM 990, PART VI, SECTION B, LINE 11B IN THE FOURTH QUARTER OF THE FISCAL YEAR, THE AUDIT & COMPLIANCE COMMITTEE ARE PROVIDED WITH A DRAFT COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES. THE AUDIT & COMPLIANCE COMMITTEE MEETS WITH ITS TAX PREPARER TO REVIEW THE DRAFT FORM 990 BEFORE IT IS FILED WITH THE IRS. ADDITIONALLY, THE COMPENSATION COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE COMPENSATION SECTIONS OF THE FORM 990, AND THE CONFLICT-OF-INTEREST COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE CONFLICT-OF-INTEREST SECTIONS OF THE FORM 990 FOR REVIEW BEFORE THE FINALIZED DOCUMENT IS FILED WITH THE IRS. EACH VOTING MEMBER OF THE BOARD IS PROVIDED WITH A FINAL COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD HAS A CONFLICT-OF-INTEREST COMMITTEE TO MANAGE BOARD MEMBER CONFLICTS OF INTEREST. NEW BOARD MEMBERS ARE GIVEN A COPY OF THE BOARD'S CONFLICT OF INTEREST POLICY AND ARE REQUIRED TO COMPLETE A CONFLICT-OF-INTEREST DISCLOSURE FORM UPON JOINING THE BOARD. ADDITIONALLY, ALL BOARD MEMBERS COMPLETE A CONFLICT-OF-INTEREST DISCLOSURE UPDATE AT LEAST ANNUALLY. THE CONFLICT-OF-INTEREST COMMITTEE OF THE BOARD REVIEWS THE NEW BOARD MEMBER AND ANNUAL CONFLICT-OF-INTEREST DISCLOSURE STATEMENTS AND DISCUSSES, RESOLVES, AND MANAGES MEMBER CONFLICTS OF INTEREST, WITH OPPORTUNITY FOR APPEAL TO THE FULL BOARD. THE ORGANIZATION HAS A CHIEF COMPLIANCE OFFICER AND COMPLIANCE DEPARTMENT, WHICH ADMINISTER THE CONFLICT-OF-INTEREST DISCLOSURE PROCESS FOR ALL EMPLOYEES IN CLINICAL, RESEARCH, AND SELECT ADMINISTRATIVE DEPARTMENTS, AS WELL AS EMPLOYEES IDENTIFIED AS SUPERVISORS OR WHO HAVE PURCHASING AUTHORITY. ALL SUCH EMPLOYEES COMPLETE CONFLICT OF INTEREST TRAINING AND A CONFLICT-OF-INTEREST DISCLOSURE ANNUALLY. DISCLOSURES IDENTIFIED AS AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST ARE ADDRESSED BY THE COMPLIANCE OFFICE WITH INVOLVEMENT OF THE INSTITUTIONAL CONFLICT-OF-INTEREST COMMITTEE AS APPROPRIATE. DEPENDING ON THE FACTS AND CIRCUMSTANCES, THE ACTIVITY MAY BE MANAGED PURSUANT TO A MANAGEMENT PLAN, OR PROHIBITED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE ("COMMITTEE") OF THIS ORGANIZATION IS COMPRISED OF INDEPENDENT MEMBERS OF THE ORGANIZATION'S GOVERNING BOARD. THE COMMITTEE IS RESPONSIBLE FOR REGULARLY REVIEWING AND APPROVING TOTAL REMUNERATION PAID TO THE CEO, CERTAIN OTHER OFFICERS, AND CERTAIN OTHER EMPLOYEES. THE BOARD HAS ADOPTED A WRITTEN EXECUTIVE COMPENSATION PHILOSOPHY, WHICH THE COMMITTEE FOLLOWS WHEN IT REVIEWS AND APPROVES COMPENSATION AND BENEFITS. THE EXECUTIVE COMPENSATION PHILOSOPHY RECOGNIZES THE CRITICAL NEED TO HAVE AND RETAIN EXECUTIVES WHO CONSISTENTLY DEMONSTRATE SUPERIOR LEVELS OF PERFORMANCE SO THAT THE ORGANIZATION CAN FULFILL ITS CHARITABLE MISSION AND STRATEGIC OBJECTIVES. THE COMMITTEE APPROVES "TOTAL REMUNERATION," WHICH INCLUDES BOTH CURRENT AND DEFERRED COMPENSATION AND ALL EMPLOYEE BENEFITS BOTH QUALIFIED AND NON-QUALIFIED, ON AT LEAST AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF DISQUALIFIED PERSONS IS REASONABLE. TO ASSIST WITH THE REVIEW, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED INDEPENDENT CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTH CARE ORGANIZATIONS AND HEALTHCARE FUNDRAISING ORGANIZATIONS AND RECEIVES A REPORT SUMMARIZING NATIONAL AND REGIONAL MARKET DATA FOR COMPARABLE ORGANIZATIONS AND AN OPINION LETTER RELATING TO THE REASONABLENESS OF EACH REVIEWED EMPLOYEE'S TOTAL COMPENSATION AND BENEFITS. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS AS NECESSARY TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. THE COMMITTEE'S PROCESS IS INTENTIONALLY STRUCTURED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986. THE COMPENSATION APPROVED BY THE COMMITTEE IS REPORTED IN EXECUTIVE SESSION TO THE FULL BOARD BY THE CHAIR AND VICE CHAIR OF THE COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS ARE AVAILABLE FROM THE HOSPITAL'S WEBSITE. GOVERNING DOCUMENTS AND THE CONFLICT OF INTEREST POLICY ARE MADE AVAILABLE ONLY AS REQUIRED BY APPLICABLE STATE LAW. FORM 990, PART IX, LINE 11G PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 122,165,249. MANAGEMENT AND GENERAL EXPENSES 32,956,571. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 155,121,820. REPAIRS & MAINTENANCE: PROGRAM SERVICE EXPENSES 24,188,616. MANAGEMENT AND GENERAL EXPENSES 4,270,225. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 28,458,841. PHYSICIAN FEES: PROGRAM SERVICE EXPENSES 8,800,379. MANAGEMENT AND GENERAL EXPENSES 1,016,049. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 9,816,428. FORM 990, PART XI, LINE 9: CHANGE IN INTEREST IN NET ASSETS OF ALSAC WITHOUT DONOR RESTRICTIONS 791,051,488. CHANGE IN INTEREST IN NET ASSETS OF ALSAC WITH DONOR RESTRICTIONS 85,675,341. CHILDREN'S GMP LLC 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 474475625 BIOTHERAPEUTICS MANUFACTURER TN 1183446 2784943 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC THANKS & GIVING LLC 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 201310435 ROYALTY INCOME FROM RECORD SALES TN 0 10182 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC THE RIGHT WORDS LLC 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 954878579 ROYALTY INCOME FROM BOOK SALES NY 0 0 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC ST JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 813240987 HIGHER EDUCATION TN 462328 1952110 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC ST JUDE CHILDREN'S RESEARCH HOSPITAL HOME CARE LLC 595 DANNY THOMAS PLACE SUITE K-1250 MEMPHIS TN 31805 852379541 HOME HEALTH SERVICE PROVIDER TN 25940 751220 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC ST JUDE GLOBAL OPERATIONS PLATFORM LLC 262 DANNY THOMAS PLACE MEMPHIS TN 381053678 991800296 GLOBAL ACTIVITIES DE 0 0 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC 501 ST JUDE PLACE MEMPHIS TN 381053678 351044585 SOLICIT SUPPORT FOR OPERATION OF ST. JUDE IL 501(C)(3) 7 N/A 0 0 0 1 0 0 0 0 0 0 0 1 0 1 1 1 1 1 0 0